Comparative Safety Study of New Sinecort Formulation Versus Positive Control

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Healthy
Interventions
DRUG

Dexpanthenol (Sinecort, BAY81-2996)

1 squeeze of Sinecort cream sufficient to cover the area of the application chamber, (=50 mikro liter)

DRUG

Positive control, Na-laurylsulfat-solution

50 mikro liter of 0.5 % Sodium-laurylsulfate-solution

DEVICE

Untreated skin under application chamber

Application of treatment chamber as in arm 1 and arm 2 on untreated skin

Trial Locations (1)

48155

Münster

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY